Insys Therapeutics (INSY) Appoints Andrew G. Long as CEO
April 15, 2019 8:32 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
